Amarin Targets AstraZeneca In Suit Over Heart Medication
Amarin Pharmaceuticals Ireland Ltd. on Tuesday hit AstraZeneca Pharmaceuticals LP with a lawsuit alleging that the company's heart medication Epanova will infringe on Amarin's patent for Vascepa, marking the second lawsuit within a...To view the full article, register now.
Already a subscriber? Click here to view full article